Bionano Genomics, Inc. (Nasdaq: BNGO) today announced publication of a peer-reviewed study in Modern Pathology showing that optical genome mapping (OGM) detected genomic abnormalities in 97.8% of ...
Nabsys 2.0, LLC (Nabsys), a developer of electronic genome mapping (EGM) technology, today announced that renowned cytogeneticist Brynn Levy, M.Sc.(Med)., Ph.D., FACMG, a Professor in the Department ...
On May 29, 2026, Kuva Labs, Inc. (“Kuva” or “Parent”) and Lisata Therapeutics, Inc. (“Lisata”) (Nasdaq: LSTA), together with Kuva’s wholly owned subsidiary Kuva Acquisition Corp. (“Kuva Acquisition”), ...
Liminatus Pharma, Inc. (“Liminatus” or the “Company”) today announced that it has entered into a definitive Merger Agreement dated May 17, 2026, with InnocsAI LLC (“InnocsAI”), a biotechnology company ...
Fanconi anemia (FA), a rare genetic disorder marked by bone marrow failure, congenital anomalies, and cancer predisposition, ...
Dana-Farber’s Katherine Janeway, M.D., discusses how reimbursement policies for molecular diagnostics have failed to keep pace with scientific evidence, leaving gaps in the care for pediatric bone ...
A new review highlights how human evolution has shaped the presence of pathogenic variations in DNA damage repair (DDR) genes, offering a new perspective on why modern populations face increased ...
Modifiable risk factors such as alcohol consumption, BMI, dietary patterns and smoking could shift cancer risk as much as 60% ...
Researchers at University of California San Diego have developed a new artificial intelligence (AI) model that can translate ...
Grail's multi-cancer blood test can find cancer — but there's still one big problem with how it works.
The first map counted Kim Johnson-Burdge. Ron Peperoni was on it, too. And Peter Matejczyk. And 38 of their other neighbors who had cancer, like them. But it did not include Edward Burke, the lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results